Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced ...
AUScelerate and the Shanghai Center of Biomedicine Development have signed a Memorandum of Understanding (MoU) to build ...
Biopharmaceutical manufacturing is entering a period of significant change. With over 2000 biological therapeutics in de...
How will the new investment accelerate the development of TAVST01? When do you plan to launch the product in the market?...
US-based Celularity Inc., a longevity-focused regenerative and cellular medicine company, and Singaporean startup M...
The World Health Organization (WHO) has designated the Global Harmonisation Centre (GHC) in the Republic of Korea as a...
Cell Therapies has manufactured and released the first clinical dose for the KOALA trial, a first-in-human study evaluat...
Japan-based Shimadzu Corporation has invested in OptQC Inc., a startup originating from The University of Tokyo, through...
A mobile clinic has been launched as part of an initiative of The University of Queensland (UQ) and the Australian Cance...
Artificial intelligence is increasingly being applied across early-stage drug discovery, but translating computational p...
Drug delivery technologies have become increasingly important as pharmaceutical developers work with complex molecules, ...
South Korea-based Hanmi Pharm has entered into an exclusive licensing agreement with Genentech, a member of the Roche Gr...
Akeso has received clinical trial clearance from China’s Center for Drug Evaluation for AK157D1, a next-generation...
CureGene has dosed the first participant in an Australian Phase I clinical trial of CG-0416, an investigational oral liv...
CStone Pharmaceuticals has received approval from China’s National Medical Products Administration to initiate cli...
The Hong Kong Applied Science and Technology Research Institute (ASTRI) and Saint Francis University (SFU), US have sign...
South Korea based Rznomics Inc, a biopharmaceutical company specialising in the development of RNA-based gene therapies,...
Telix Pharmaceuticals has reported continued progress across its radiopharmaceutical imaging and therapeutic pipeline du...
Brii Biosciences has advanced its internally developed mRNA therapeutic cancer vaccine BRII-5395 into clinical evaluatio...
US-based Charles River Laboratories International, and Medigen Vaccine Biologics Corp. (MVC), headquartered in Taiwan, h...
South Korea-based Crescom, a company specialising in musculoskeletal medical artificial intelligence (AI), has signed a ...
Brown University Health and Arcamyra Therapeutics are preparing to launch a Phase I clinical trial of ACM-CpG in patient...
Researchers from A*STAR have identified spatial differences in early brain development that could help explain why autis...
Australia-based Monash University has signed a Memorandum of Understanding (MoU) with Vietnam's Becamex Group, establish...
Asia-Pacific continues to attract investment across pharmaceutical manufacturing, biotechnology, vaccines, advanced ther...
